Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension

ClinicalTrials.gov ID: NCT00817414

Public ClinicalTrials.gov record NCT00817414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study determined the maximum dose of LCI6999 with respect to effect on the ACTH-stimulated cortisol response in participants with hypertension.

Study identification

NCT ID
NCT00817414
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis
Industry
Enrollment
63 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2009
Primary completion
Aug 11, 2009
Completion
Aug 11, 2009
Last update posted
Jun 1, 2021

2009

United States locations

U.S. sites
10
U.S. states
5
U.S. cities
10
Facility City State ZIP Site status
Impact Clinical Trials Beverly Hills California 90211
Associated Pharmaceutical Research Center, Inc Buena Park California 90620
Innovative Clinical Research, Inc Harbor City California 90710
Long Beach Center for Clinical Research Long Beach California 90806
Metro Clinical Research Littleton Colorado 80120
Clinical Study Center of Asheville, LLC Asheville North Carolina 28801
Northstate Clinical Research Lenoir North Carolina 28645
Tipton Medical & Diagnostic Center Tipton Pennsylvania 16684
Punzi Medical Center Carrollton Texas 75006
dgd Research, Inc San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

Recently updated Hypertension trials

Other public records listing Hypertension. Sorted by last update posted; newest first. Not a recommendation.

All Hypertension trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00817414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2021 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00817414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →